Differential Distribution and Phenotype of Decidual Macrophages in Preeclamptic versus Control Pregnancies
- 1 February 2011
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 178 (2), 709-717
- https://doi.org/10.1016/j.ajpath.2010.10.011
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKDJournal of the American Society of Nephrology, 2009
- “Dermal Dendritic Cells” Comprise Two Distinct Populations: CD1+ Dendritic Cells and CD209+ MacrophagesJournal of Investigative Dermatology, 2008
- The placenta in pre-eclampsia and intrauterine growth restrictionJournal of Clinical Pathology, 2008
- Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axisJournal of Clinical Investigation, 2008
- Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive PhenotypePLOS ONE, 2008
- DC-SIGN+ CD163+ Macrophages Expressing Hyaluronan Receptor LYVE-1 Are Located within Chorion Villi of the PlacentaPlacenta, 2008
- Stranger in a strange landImmunological Reviews, 2006
- Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia developAmerican Journal of Obstetrics and Gynecology, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003